Disposition of tradable shares by Jill Sanchez of Vaccinex at 1045.8 subject to Rule 16b-3
Slightly above 67% of Vaccinex's investor base is looking to short. The analysis of overall sentiment of trading Vaccinex stock suggests that many investors are alarmed at this time. Vaccinex's investing sentiment can be driven by a variety of factors including economic data, Vaccinex's earnings reports, geopolitical events, and overall market trends.
Vaccinex |
Filed transaction by Vaccinex Officer: Interim Cfo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Vaccinex Fundamental Analysis
We analyze Vaccinex's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vaccinex using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vaccinex based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
Vaccinex is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Vaccinex Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vaccinex stock to make a market-neutral strategy. Peer analysis of Vaccinex could also be used in its relative valuation, which is a method of valuing Vaccinex by comparing valuation metrics with similar companies.
Peers
Vaccinex Related Equities
| MNPR | Monopar Therapeutics | 16.07 | ||||
| TARA | Protara Therapeutics | 10.32 | ||||
| ERAS | Erasca | 6.20 | ||||
| ELDN | Eledon Pharmaceuticals | 1.72 | ||||
| SABS | SAB Biotherapeutics | 1.18 | ||||
| RNXT | RenovoRx | 0.99 | ||||
| FBRX | Forte Biosciences | 2.15 | ||||
| GOVX | GeoVax Labs | 2.70 | ||||
| SRZN | Surrozen | 3.12 | ||||
| ANEB | Anebulo Pharmaceuticals | 3.33 | ||||
| SLRX | Salarius Pharmaceuticals | 12.20 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Vaccinex Stock
If you are still planning to invest in Vaccinex check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaccinex's history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |